131 related articles for article (PubMed ID: 34113555)
1. Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report.
He Y; Wang L; Li X; Zhang T; Song T; Zhang J; Yu Y; Chen S; Song H
Front Oncol; 2021; 11():596342. PubMed ID: 34113555
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of ascending colon with pMMR/MSS showed a partial response to PD-1 blockade combined with chemotherapy: A case report.
Liu Y; Du J; Zhang P; Meng W; Xiao H
Front Oncol; 2023; 13():1051786. PubMed ID: 36969074
[TBL] [Abstract][Full Text] [Related]
3. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.
Liu X; Yao J; Song L; Zhang S; Huang T; Li Y
J Immunother Cancer; 2019 Aug; 7(1):204. PubMed ID: 31383016
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report.
Zhong L; Liu X; Li Z; Zhang X; Wang Y; Peng W
Front Oncol; 2021; 11():783158. PubMed ID: 35096582
[TBL] [Abstract][Full Text] [Related]
5. Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade.
Sui M; Li Y; Wang H; Luo Y; Wan T; Wang X; Hu B; Cheng Y; Lv X; Xin X; Xu Q; Wang G; Lu S
J Immunother Cancer; 2019 May; 7(1):125. PubMed ID: 31064408
[TBL] [Abstract][Full Text] [Related]
6. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
[TBL] [Abstract][Full Text] [Related]
7. PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report.
Yang J; Xing P; Kong Y; Xu M; Zhang L
Front Oncol; 2023; 13():1078915. PubMed ID: 37188188
[TBL] [Abstract][Full Text] [Related]
8. A PD-L1 Negative Advanced Gastric Cancer Patient With a Long Response to PD-1 Blockade After Failure of Systematic Treatment: A Case Report.
Zhang F; Zhang J; Zhao L; Zhai M; Zhang T; Yu D
Front Immunol; 2021; 12():759250. PubMed ID: 34950137
[TBL] [Abstract][Full Text] [Related]
9. A new strategy for immunotherapy of microsatellite-stable (MSS)-type advanced colorectal cancer: Multi-pathway combination therapy with PD-1/PD-L1 inhibitors.
Cai L; Chen A; Tang D
Immunology; 2024 Mar; ():. PubMed ID: 38517066
[TBL] [Abstract][Full Text] [Related]
10. Case report: mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance.
Chen KH; Yuan CT; Tseng LH; Shun CT; Yeh KH
J Hematol Oncol; 2016 Mar; 9():29. PubMed ID: 27012666
[TBL] [Abstract][Full Text] [Related]
11. Case Report: A management strategy and clinical analysis of primary squamous cell carcinoma of the colon.
Wu X; Su S; Wei Y; Hong D; Wang Z
Front Oncol; 2023; 13():1265421. PubMed ID: 37901330
[TBL] [Abstract][Full Text] [Related]
12. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sintilimab and fruquintinib combination treatment in the management of microsatellite-stable metastatic colorectal cancer: a case report.
Lin S; Chen W; Chen Z; Liang J; Zhong L; Jiang M
Ann Transl Med; 2022 Mar; 10(6):380. PubMed ID: 35433988
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tyrosine kinase inhibitors combined with antiprogrammed cell death protein 1 antibody in tyrosine kinase inhibitor-responsive patients with microsatellite stable/proficient mismatch repair metastatic colorectal adenocarcinoma: protocol for open-label, single-arm trial.
Dong Q; Diao Y; Sun X; Zhou Y; Ran J; Zhang J
BMJ Open; 2022 Apr; 12(4):e049992. PubMed ID: 35379611
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report.
Cheng X; Li X; Yang X; Fang S; Wang Z; Liu T; Zheng M; Zhai M; Yang Z; Shen T
Cureus; 2023 Jul; 15(7):e42347. PubMed ID: 37621810
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancer.
Liu S; Kong P; Wang X; Yang L; Jiang C; He W; Quan Q; Huang J; Xie Q; Xia X; Zhang B; Xia L
Oncol Lett; 2019 Feb; 17(2):2335-2343. PubMed ID: 30675299
[TBL] [Abstract][Full Text] [Related]
18. Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report.
Babyshkina N; Popova N; Grigoryev E; Dronova T; Gervas P; Dobrodeev A; Kostromitskiy D; Goldberg V; Afanasiev S; Cherdyntseva N
Drug Target Insights; 2024; 18():4-7. PubMed ID: 38283860
[TBL] [Abstract][Full Text] [Related]
19. Metastatic Colorectal Cancer Patient With Microsatellite Stability and BRAF
Fang C; Lin J; Zhang T; Luo J; Nie D; Li M; Hu X; Zheng Y; Huang X; Xiao Z
Front Oncol; 2021; 11():652394. PubMed ID: 33987088
[TBL] [Abstract][Full Text] [Related]
20. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
